Jamie I Forrest
Overview
Explore the profile of Jamie I Forrest including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reis G, Augusto Dos Santos Moreira Silva E, Carla Medeiros Silva D, Thabane L, Santiago Ferreira T, Vitor Quirino Dos Santos C, et al.
Am J Clin Nutr
. 2024 Sep;
120(3):602-609.
PMID: 39232602
Background: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clinical consequences to COVID-19 infections. Objectives: This study aimed to determine whether spirulina is...
2.
Reis G, Cancado Monteiro Savassi L, Santiago Ferreira T, Lanna Franca Reis L, Izabel Campos Simplicio M, Barra Ribeiro L, et al.
JAMA Netw Open
. 2024 May;
7(5):e2410335.
PMID: 38767921
Importance: Matched placebo interventions are complex and resource intensive. Recent evidence suggests matched placebos may not always be necessary. Previous studies have predominantly evaluated potential bias of nonmatched placebos (ie,...
3.
Reis G, Augusto Dos Santos Moreira Silva E, Carla Medeiros Silva D, Thabane L, Helena de Souza Campos V, Santiago Ferreira T, et al.
Ann Intern Med
. 2023 Apr;
176(5):667-675.
PMID: 37068273
Background: Previous trials have demonstrated the effects of fluvoxamine alone and inhaled budesonide alone for prevention of disease progression among outpatients with COVID-19. Objective: To determine whether the combination of...
4.
Reis G, Moreira Silva E, Medeiros Silva D, Thabane L, Campos V, Ferreira T, et al.
N Engl J Med
. 2023 Feb;
388(6):518-528.
PMID: 36780676
Background: The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear. Methods: We conducted a...
5.
Mills F, Reis G, Wilson L, Thorlund K, Forrest J, Guo C, et al.
Am J Trop Med Hyg
. 2022 Nov;
108(1):101-106.
PMID: 36379209
To date, two published randomized trials have indicated a clinical benefit of early treatment with fluvoxamine versus placebo for adults with symptomatic COVID-19. Using the results of the largest of...
6.
Nsanzimana S, Rawat A, Wilson L, Forrest J, Reis G, Ramagopalan S, et al.
Am J Trop Med Hyg
. 2022 Nov;
107(6):1162-1165.
PMID: 36375450
COVID-19 underscores the need to reimagine North-South partnerships and redefine best practices for building public health and research capacity to address emergent health threats and pandemic preparedness in low- and-middle...
7.
Jhuti D, Rawat A, Guo C, Wilson L, Mills E, Forrest J
Infect Dis Ther
. 2022 Apr;
11(3):953-972.
PMID: 35445964
Interferon (IFN) therapies are used to treat a variety of infections and diseases and could be used to treat SARS-CoV-2. However, optimal use and timing of IFN therapy to treat...
8.
Reis G, Silva E, Silva D, Thabane L, Milagres A, Ferreira T, et al.
N Engl J Med
. 2022 Mar;
386(18):1721-1731.
PMID: 35353979
Background: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute...
9.
Guo C, Harari O, Chernecki C, Thorlund K, Forrest J
Am J Trop Med Hyg
. 2022 Mar;
PMID: 35263710
Fluvoxamine is widely prescribed as an antidepressant. Recent studies show the drug may have a clinical benefit in treating COVID-19. We aimed to perform a meta-analysis of the existing randomized...
10.
Remera E, Nsanzimana S, Chammartin F, Semakula M, Rwibasira G, Malamba S, et al.
J Acquir Immune Defic Syndr
. 2022 Feb;
89(4):423-427.
PMID: 35202049
Background: Voluntary assisted partner notification (VAPN) services that use contract, provider, or dual referral modalities may be efficient to identify individuals with undiagnosed HIV infection. We aimed to assess the...